Alpha-synuclein aggregates increase the conductance of substantia nigra dopamine neurons, an effect partly reversed by the KATP channel inhibitor glibenclamide by Hill, Emily et al.
Copyright © 2020 Hill et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution
4.0 International license, which permits unrestricted use, distribution and reproduction in any
medium provided that the original work is properly attributed.
Research Article: New Research | Disorders of the Nervous System
Alpha-synuclein aggregates increase the
conductance of substantia nigra dopamine
neurons, an effect partly reversed by the KATP
channel inhibitor glibenclamide
https://doi.org/10.1523/ENEURO.0330-20.2020
Cite as: eNeuro 2020; 10.1523/ENEURO.0330-20.2020
Received: 27 July 2020
Revised: 13 October 2020
Accepted: 18 October 2020
This Early Release article has been peer-reviewed and accepted, but has not been through
the composition and copyediting processes. The final version may differ slightly in style or
formatting and will contain links to any extended data.
Alerts: Sign up at www.eneuro.org/alerts to receive customized email alerts when the fully
formatted version of this article is published.
 
 1 
Alpha-synuclein aggregates increase the conductance of 1 
substantia nigra dopamine neurons, an effect partly reversed 2 
by the KATP channel inhibitor glibenclamide.  3 
E. Hill1, R. Gowers2,3, M. J. E. Richardson2, M. J. Wall1* 4 
 5 
1 School of Life Sciences, Gibbet Hill Campus, University of Warwick, CV4 7AL 6 
2 Warwick Mathematics Institute, University of Warwick, CV4 7AL 7 
3 Institute for Theoretical Biology, Department of Biology, Humboldt-Universität zu Berlin, 8 
Philippstraße 13, Haus 4, 10115, Berlin, Germany 9 
 10 
* Corresponding author: 11 
Dr Mark Wall 12 
School of Life Sciences 13 
University of Warwick 14 
CV4 7AL 15 
Mark.wall@warwick.ac.uk 16 
 17 
Author contributions: EH and MJW designed the experiments. EH performed the 18 
experiments. EH, RG and MJER analysed the data. EH, MJER and MJW wrote the 19 
manuscript.   20 
Funding:  EH holds a BBSRC-funded PhD Studentship. RG held an EPSRC funded PhD 21 
studentship.  22 
Conflicts of Interest: The authors declare that there are no competing or conflicting 23 
interests 24 
 
 2 
 25 
Abstract  26 
Dopaminergic neurons in the substantia nigra pars compacta (SNpc) form an important part 27 
of the basal ganglia circuitry, playing key roles in movement initiation and co-ordination. A 28 
hallmark of Parkinson’s disease (PD) is the degeneration of these SNpc dopaminergic 29 
neurons leading to akinesia, bradykinesia and tremor. There is gathering evidence that 30 
oligomeric alpha synuclein ( -syn) is one of the major pathological species in PD, with its 31 
deposition in Lewy bodies closely correlated with disease progression. However the precise 32 
mechanisms underlying the effects of oligomeric -syn on dopaminergic neuron function 33 
have yet to be fully defined. Here we have combined electrophysiological recording and 34 
detailed analysis to characterise the time-dependent effects of -syn aggregates (consisting 35 
of oligomers and possibly small fibrils) on the properties of SNpc dopaminergic neurons. The 36 
introduction of -syn aggregates into single dopaminergic neurons via the patch electrode 37 
significantly reduced both the input resistance and the firing rate without changing the 38 
membrane potential. These effects occurred after 8-16 minutes of dialysis but did not occur 39 
with the monomeric form of -syn. The effects of -syn aggregates could be significantly 40 
reduced by pre-incubation with the ATP-sensitive potassium channel (KATP) inhibitor 41 
glibenclamide. This data suggests that accumulation of -syn aggregates in dopaminergic 42 
neurons may chronically activate KATP channels leading to a significant loss of excitability 43 
and dopamine release.  44 
 45 
 46 
Significance statement  47 
Alpha synuclein oligomers are one of the key toxic species in Parkinson’s disease, with their 48 
accumulation leading to dopamine neuron dysfunction. Introducing alpha synuclein 49 
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aggregates (oligomers and possibly small fibrils) into single substantia nigra dopamine 50 
neurons led to a marked increase in whole cell conductance and a corresponding fall in the 51 
firing rate. These changes were diminished by inhibiting ATP-sensitive K channels. Thus, the 52 
build-up of alpha synuclein oligomers during the progression of Parkinson’s disease could 53 
chronically shunt dopamine neurons, via channel activation (which may include KATP 54 
channel activation) to reduce dopamine release.  55 
Introduction  56 
Mid-brain dopaminergic neurons (DNs) play major roles in the control of movement, emotion, 57 
arousal and reward behaviour. They possess large numbers of projections, have pacemaker 58 
activity (firing action potentials at rest) and are therefore highly energy intensive. This makes 59 
them particularly sensitive to oxidative damage (which can lead to mitochondrial dysfunction, 60 
Michel et al, 2016) and they are the most susceptible to degeneration in Parkinson’s disease 61 
(PD, Damier et al, 1999). DNs are lost over the progression of PD, primarily from the 62 
substantia nigra pars compacta (SNpc) but later in the disease there is also loss from the 63 
ventral tegmental area (VTA). Symptoms of PD only become apparent when 70-80 % of the 64 
dopamine input to the striatum is lost (Bernheimer et al, 1973) making it difficult to detect PD 65 
at early stages. Understanding what happens to these dopaminergic neurons early in 66 
pathology is important as it could provide improved diagnosis and potentially new targets to 67 
prevent or slow disease progression.  68 
Alpha synuclein ( -syn) is a small, native intracellular protein, found primarily at presynaptic 69 
terminals (Iwai et al, 1995) where it contributes to neurotransmitter uptake and vesicle 70 
recycling. It can also localise to the mitochondria and the nucleus (Burre et al, 2010). 71 
Molecules of -syn are intrinsically disordered (Alderson and Markley, 2013) but can 72 
become ordered upon aggregation, triggering a pathological cascade. First -syn 73 
aggregates into soluble oligomers (dimers and trimers) and then it can go on to form longer 74 
fibrils and ultimately it can form insoluble Lewy Bodies (LB; Spillantini et al, 1997). Lewy 75 
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bodies are a key pathological marker in the brains of PD patients with their abundance 76 
correlating with disease severity. LB formation involves a complex interplay between α-syn 77 
fibrillization, post-translational modifications, and interactions of -syn aggregates with 78 
membranous organelles. LB formation can lead to the disruption of mitochondrial function, to 79 
synapse dysfunction and of a decline in general cell function (Mahul-Mellier et al. 2020). 80 
However, there is also evidence that the small soluble oligomers contribute to toxicity 81 
(Winner et al, 2011; reviewed in Bengoa-Vergniory et al, 2017). At the presynaptic terminal, 82 
oligomeric -syn can induce synaptic dysfunction by disrupting vesicle trafficking (Jakes et 83 
al, 1994). It also interferes with synaptobrevin in the SNARE complex which is vital for the 84 
fusion of vesicles with the plasma membrane for neurotransmitter release (Burre et al, 2010; 85 
Murphy et al, 2000; Lashuel et al, 2013). Kaufmann et al (2016) showed that -syn 86 
oligomers reduced the excitability and input resistance of cortical pyramidal cells.  87 
In this study, we have used whole-cell patch-clamp recording to provide a detailed 88 
characterisation of the electrophysiological effects of introducing aggregated -syn 89 
(oligomers plus a small proportion of fibrils) into single dopaminergic neurons in the 90 
substantia nigra of mouse brain slices. Since the -syn aggregates are only introduced into 91 
one neuron, there will be no compensation within the circuit and any slow cellular uptake 92 
steps (which may occur if -syn aggregates were applied extracellularly) are removed. Each 93 
cell acts as its own internal control, as at the time of whole-cell breakthrough the -syn 94 
aggregates will not have diffused into the neuron This approach has successfully been used 95 
to examine the effects of oligomeric tau on pyramidal neurons (Hill et al, 2019) and the 96 
effects of -syn oligomers on layer-V pyramidal cells in the neocortex (Kaufmann et al, 97 
2016).   98 
As well as using standard-IV relationships (with step-current injections) to measure the 99 
changes in dopaminergic neuron electrophysiology, we have also utilised the dynamic-IV 100 
protocol. This was originally applied with cortical pyramidal neurons and interneurons (Badel 101 
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et al, 2008a; Badel et al, 2008b; Harrison et al, 2015) and can be used to develop simplified, 102 
but empirically verified quantitative models of their responses. Though the cortical cells in 103 
the original study exhibit non-linear voltage and calcium-activated currents, under ongoing 104 
in-vivo-like fluctuating current stimulation their response could be well captured by an 105 
effective linear I-V curve (away from action potential threshold). Dopaminergic neurons, 106 
however, have more strongly expressed non-linearities (Richards et al, 1997; Neuhoff et al 107 
2002), and it can therefore be anticipated that the resulting dynamic-IV curves will diverge 108 
from an Ohmic linear form below threshold. Despite this, we have determined that the 109 
dynamic IV can still be used to accurately extract a number of key electrophysiological 110 
parameters.   111 
Using these approaches, we have characterised the real-time effects of -syn aggregates on 112 
the electrophysiological properties of single neurons. We find that their major effect is to 113 
induce an increase in whole-cell conductance, which significantly dampens neuronal 114 
excitability and firing rate. These effects were partially but significantly reduced by 115 
glibenclamide, an ATP-sensitive K channel inhibitor, suggesting a role for these channels in 116 
the pathological actions of -syn aggregates.  117 
Methods  118 
Preparation of acute brain slices  119 
All experiments were approved by the local Animals Welfare and Ethics Board (AWERB) at 120 
the University of Warwick. C57/Bl6 mice (2-3 weeks; of either sex) were killed by cervical 121 
dislocation and decapitated in accordance with the U.K. Animals (Scientific Procedures) Act 122 
(1986). The brain was rapidly dissected and kept on ice. The cerebellum was removed, and 123 
the rostral section of the brain was trimmed. The brain was then mounted rostral side down. 124 
Coronal slices (350 M) were cut with a Microm HM 650V microslicer in cold (2-4°C) high 125 
Mg2+, low Ca2+ aCSF, composed of (mM): 127 NaCl, 1.9 KCl, 8 MgCl2, 0.5 CaCl2, 1.2 126 
KH2PO4, 26 NaHCO3, 10 D-glucose (pH 7.4 when bubbled with 95% O2 and 5% CO2, 300 127 
 
 6 
mOSM). Slices were stored at 34 °C in standard aCSF (1 mM Mg2+ and 2 mM Ca2+) for at 128 
least 1 hour before recording and were viable for up to 8 hours.  129 
Preparation of alpha synuclein aggregates 130 
Recombinant human alpha-synuclein protein aggregates were purchased from Abcam 131 
(ab218819). These aggregates are advertised as pre-formed fibrils (PFFs) which was 132 
confirmed using negative-stain electron microscopy. Since we wanted to introduce smaller 133 
oligomeric species of alpha synuclein into neurons, the PFFs were first broken down into 134 
smaller aggregates before recordings were made. PFF samples were sonicated (as in 135 
Polinski et al, 2018) for 15 minutes (50-60 Hz) at room temperature using a Grant Ultrasonic 136 
XUBA1 bath. . Recombinant human alpha-synuclein protein in monomeric form (ab218818) 137 
was used as a control and negative-stain electron microscopy was used to confirm it was not 138 
aggregated.  139 
Transmission electron microscopy 140 
Formvar/carbon-coated 300-mesh copper grids (#S162, Agar Scientific) were glow-141 
discharged using the ELMO system from Cordouan Technologies. Five microliters of alpha 142 
synuclein species (monomer, PFF or sonicated PFFs) were pipetted onto the grid and 143 
allowed to bind for 1 min. Excess samples were removed with a strip of filter paper, and 5 μl 144 
of 2% uranyl acetate added for 1 min. After removing the excess stain with a strip of filter 145 
paper, the grids were imaged using a JEOL-2100F transmission electron microscope. 146 
Whole-cell patch-clamp recording 147 
A slice was transferred to the recording chamber, submerged and perfused (2-3 ml/min-1) 148 
with aCSF at 30-32 °C. Slices were visualized using IR-DIC optics with an Olympus 149 
BX151W microscope (Scientifica, Bedford UK) and a CCD camera (Hitachi). Whole-cell 150 
current-clamp recordings were made from dopaminergic neurons in the substantia nigra pars 151 
compacta using patch pipettes (5–10 MΩ) manufactured from thick-walled glass (Harvard 152 
Apparatus, Edenbridge, UK). Intracellular solution was filtered before use (0.2 m) and 153 
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contained in (mM): potassium gluconate 135, NaCl 7, HEPES 10, EGTA 0.5, 154 
phosphocreatine 10, MgATP 2, NaGTP 0.3, 293 mOSM, pH 7.2). The intracellular solution 155 
was filtered (2-4 m) before the addition of -syn aggregates (2 μl of a 69 μM stock into 275 156 
μl intracellular solution to give final concentration of 500 nM) as filtering reduces the 157 
aggregate concentration (Hill et al, 2020; Kaufmann et al, 2016). The molar concentrations 158 
of alpha-synuclein species are based on the molar mass of monomeric alpha-synuclein (14 159 
kD) due to the likelihood that samples will contain a range of aggregate sizes. This method 160 
has been used in similar studies (see Hill et al, 2019 and Thakur et al, 2019) and will result 161 
in an overestimate of aggregate concentration. For example if aggregates are on average 162 
tetramers, then the concentration of aggregates will be 4x lower than reported.  A subset of 163 
neurons were filled with AF594 dye (50 M) via the patch pipette for immunohistochemistry. 164 
Voltage recordings were made using an Axon Multiclamp 700B amplifier (Molecular Devices, 165 
USA) and digitised at 20 KHz. Data acquisition and analysis were performed using pClamp 166 
10 (Molecular Devices). Recordings from neurons that had a resting membrane potential of 167 
between -55 and – 75 mV at whole-cell breakthrough were accepted for analysis. The bridge 168 
balance was monitored throughout the experiments and any recordings where it changed by 169 
more than 20 % were discarded.  170 
 171 
Stimulation Protocols 172 
Standard IV protocol: Standard current-voltage relationships (SIV) were constructed by 173 
injecting step currents (3 s duration, with a 5 s interval) starting at -200 pA and then 174 
incrementing by either 50 or 100 pA until a regular firing pattern was induced.  175 
Naturalistic current injection:  A naturalistic, fluctuating current (40 s duration, see below for 176 
details) was injected into neurons and the resulting voltage trace was used to measure the 177 
frequency of action-potential firing (using threshold detection in Clampfit).  178 
 179 
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Immunohistochemistry  180 
After completing the electrophysiology recordings from dopaminergic neurons, with the 181 
addition of AF594 dye (50 M) in the patch pipette, slices (350 M) were fixed in 4% PFA for 182 
45 minutes at room temperature and then overnight at 4ºC. The tissue was then washed 5 183 
times for 5 minutes with PBS.  The slices were then blocked for an hour (1% BSA, 0.4% 184 
Triton 100X in PBS, 400 l per slice) then washed 3 times for 5 minutes with PBS. The 185 
primary antibodies against tyrosine hydroxylase (1:1000, Sheep), was added to the slices 186 
(250 l per slice) for an hour at room temperature and then kept at 4-8ºC overnight. Slices 187 
were washed 5 times for 5 minutes with PBS and then the secondary antibody was added 188 
(anti-sheep 488, 1:500, 200 l per slice) for 4 hours at room temperature. The slices were 189 
then washed 5 times for 5 minutes with PBS, and then mounted on glass slides with 190 
Vectashield (Vector laboratories, Peterborough UK). All imaging was carried using confocal 191 
microscopy (Leica 710 and Zen Black for image acquisition and processing). Controls were 192 
carried out without incubating with the primary antibodies and showed no fluorescence.   193 
Drugs and substances  194 
Recombinant human alpha-synuclein aggregates were purchased from Abcam (ab218819) 195 
along with the corresponding monomers (ab218818). Dopamine (HB1835) and ZD 7288 196 
(HB1152) were purchased from Hello Bio (HB1835). Glibenclamide (PHR1287) was 197 
purchased from Sigma-Aldrich.  The Sheep polyclonal Anti-Tyrosine hydroxylase was 198 
purchased from Merck (AB1542) and Donkey anti-sheep 488 secondary from Invitrogen 199 
(A11015). The Alexa Fluor 594 hydrazide dye was purchased from Molecular Probes 200 
(10072752).  201 
 202 
 203 
Statistics  204 
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Each recorded cell is one data point. All experimental conditions were measured using 205 
multiple animals as only 1 cell was recorded per slice and recording conditions were 206 
interleaved to remove bias introduced from individual animals. Data points for each 207 
experimental condition were derived from a minimum of 4 individual animals (the exact 208 
numbers are provided in the figure legends). Statistical analysis was performed using non 209 
parametric methods: Kruskal–Wallis one-way analysis of variance (ANOVAs), Mann Whitney 210 
and Wilcoxon signed-rank tests as required. All data is represented as mean and standard 211 
error of the mean with individual experiments represented by single data points. Standard 212 
deviations are given in table 1. 213 
 214 
Neuronal parameter extraction  215 
Both the standard IV-curve (response to constant current inputs) and dynamic IV-curve 216 
(Badel et al, 2008) methods were used to extract estimates for the cellular conductance 217 
under the various pharmacological conditions. The voltage was modelled by the following 218 
the current-balance equation 219 
+ =         Eq 1  220 
where C is the capacitance, Iion is the summed intrinsic current (including voltage-gated and 221 
calcium-gated currents) and Iinj in the current injected via the electrode during the different 222 
protocols. All computational modelling and data-fitting was carried out using custom written 223 
code in the Julia language (Bezanson et al, 2014) ported from published MATLAB code 224 
(Harrison et al, 2015).  225 
Standard IV curve 226 
To calculate neuronal resistance, the maximum voltage deflection to the -100 pA current 227 
step (before the sag, arrow on Fig 2A) was measured (peak neuronal resistance).  The 228 
position for the voltage measurement was determined on the voltage traces at time zero 229 
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(where there was a clear peak), and then the same position was used for the rest of the 230 
voltage traces at subsequent time points.    231 
Dynamic IV curve 232 
As well as measuring the static properties of the neuron at rest it is also useful to measure 233 
the effective parameters when the neuronal voltage is subject to a fluctuating drive, as is the 234 
case in-vivo. To this end we employed the dynamic IV-curve protocol (Badel et al, 2008) in 235 
which a stochastic current Iinj in injected into the cell to induce a fluctuating voltage response 236 
and triggering of action potentials (Fig 2B). A detailed description of the protocol has been 237 
previously published (Badel et al, 2008) as well as the computer code required (Harrison et 238 
al, 2015). In brief, a noisy current trace Iinj is generated computationally (from the sum of two 239 
Ornstein-Uhlenbeck gaussian processes with time constants fast = 3 ms and slow = 10 ms to 240 
mimic AMPA and GABAA receptor time courses) and injected into the cell with the resultant 241 
voltage measured. The voltage equation 1 can be re-arranged for the ionic current to give 242 
= −           Eq 3  243 
where the injected current is known, and the derivative can be calculated from measured 244 
voltage (with the capacitance extracted using the method in Badel et al, 2008). The ionic 245 
current and voltage time courses can then be plotted against each other (see Fig. 2C, red 246 
scattered points). Given the interaction of the gated ionic currents with the stochastic 247 
injected current, there is significant scatter in the relation. However, the ionic current can be 248 
averaged in voltage slices to provide the dynamic IV-curve (see Fig 2C, black solid line and 249 
expanded view in Fig 2D). Once the dynamic IV-curve has been obtained the various 250 
features can be extracted such as the ohmic conductance - the linear component of the IV-251 
curve at more hyperpolarised subthreshold voltage - and the excess depolarisation-activated 252 
current seen in these cells near threshold. 253 
 254 
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By using both DIV and SIV we use two independent methods that induce distinct voltage 255 
dynamics to extract neuronal parameters thereby increasing the robustness of the data. 256 
These approaches also examine the neurons under different conditions. For SIV, the 257 
parameters are extracted from neurons that are in a simple dynamical state. In contrast the 258 
fluctuations induced by the DIV protocol result in a voltage that rapidly explores a much 259 
larger range. 260 
 261 
 262 
Results 263 
Characterising dopaminergic neurons in the substantia nigra 264 
Whole-cell patch-clamp recordings were made from putative dopaminergic neurons located 265 
in the SNpc (identified by position in the slice). Neurons were initially confirmed to be SNpc 266 
dopaminergic neurons from their electrophysiological profile, which was consistent with 267 
previous studies (Grace and Onn, 1989; Richards et al 1997; Krashia et al 2017). Most of 268 
the recorded neurons displayed slow autonomous firing (36 out of 49 neurons, 73 %, mean 269 
firing rate of 1.05 ± 0.082 Hz Fig 1A) consistent with the reported properties for dopamine 270 
neurons in the SNpc (Grace and Onn, 1989). These neurons were sensitive to dopamine 271 
(Lacey et al 1989), with application of dopamine (30 M) hyperpolarising the membrane 272 
potential by 7.35 ± 1.24 mV and abolishing the spontaneous firing (Fig 1A, n = 8). The 273 
neurons showed a characteristic (Neuhoff et al, 2002) response to step-current injection (Fig 274 
1B), with a large sag in response to hyperpolarising current steps (Fig 1C) indicative of the 275 
presence of I(h). Following the termination of hyperpolarising-current steps there was a 276 
rebound potential leading to firing in 33 out of 49 neurons (68 %, Fig 1C) another 277 
characteristic of I(h). Dopamine reduced the firing in response to the positive current steps 278 
and to the naturalistic current injection (firing rate reduced to 62.7 ± 0.2 % of that in control). 279 
Dopamine also reduced the voltage response to hyperpolarising current steps (indicative of 280 
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an increase in whole-cell conductance) and also abolished the rebound firing (Fig 1D). 281 
Application of ZD7288 (100 M), a pharmacological inhibitor of I(h) in dopamine neurons  282 
(Harris and Constanti, 1995) greatly reduced the sag response produced by hyperpolarising 283 
current steps and also abolished the rebound firing, confirming that they were I(h)  mediated 284 
(Fig 1E, n = 6). Finally, to confirm that the neurons were dopaminergic, a subset of the 285 
recorded neurons (n = 9) were filled with AF594 dye via the patch pipette and 286 
immunofluorescence staining was used to confirm that they were tyrosine hydroxylase 287 
positive (Fig 1F).  288 
Detailed analysis of the electrophysiology of dopaminergic neurons in the 289 
substantia nigra 290 
We used two approaches to characterise changes that occurred when SNpc dopaminergic 291 
neurons had either -syn aggregates, monomers or vehicle introduced. The first constituted 292 
of measurements from standard IV-curve protocols during which neurons received constant-293 
current (step) inputs (Fig. 2A). The second approach measures neuronal properties using 294 
the dynamic IV-curve protocol (Badel et al, 2008a, 2008b; Harrison et al, 2015) during which 295 
neurons were stimulated by a stochastic current mimicking fluctuating synaptic drive (Fig 2B-296 
D). This methodology allows for the average ionic current at a particular voltage to be 297 
measured at a good resolution over the full voltage range. The resulting dynamic IV-curve 298 
can be used to provide capacitance, ohmic conductance at hyperpolarised regimes as well 299 
as the strength of excess current seen near threshold in these cells (see Fig. 2B-D).  It is 300 
clear that the dynamic IV curve diverges from linear at potentials above ~ -50 mV (but below 301 
action-potential threshold) which is characteristic of a depolarisation-activated outward 302 
current (Fig 2D). This effect of the outward current can be isolated by subtracting an 303 
extrapolated fit to the linear portion of the dynamic IV curve (as illustrated in the inset to Fig 304 
2D). 305 
Characterising the structure of the alpha synuclein ( -syn) aggregates 306 
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Recombinant human alpha-synuclein protein was purchased from Abcam in the form of pre-307 
formed fibril aggregates (PFFs; ab218819) and in the form of monomers (ab218818). 308 
Negative stain- transmission electron microscopy (TEM) was initially to confirm that the 309 
samples were either monomeric (Fig 3B) or PFFs (Fig 3C). To enable delivery of 310 
aggregates, mostly in oligomeric form, via the patch pipette, the PFFs were broken down. 311 
We used sonication (as in Polinski et al, 2018) for 15 minutes (50-60 Hz). We compared the 312 
structure of the -syn aggregates (sonicated PFFs) to oligomeric tau which had an annular 313 
structure (Fig 3A, Hill et al 2019) to ensure that it consisted of oligomeric species (Fig 3B). 314 
These oligomeric forms were stable for at least 3 hours on ice. While the majority of the 315 
species in our samples had an oligomeric structure, we cannot exclude the possibility that 316 
other forms of aggregates exist (for example small ~50 nm fibrils; Polinski et al, 2018). We 317 
therefore use the term aggregates rather than oligomers.  Monomeric or aggregated -syn 318 
samples were introduced into dopaminergic neurons via the patch pipette.  319 
Alpha-synuclein aggregates but not monomers have marked effects on the 320 
electrophysiological properties of SN dopaminergic neurons. 321 
We introduced either aggregated or monomeric alpha synuclein (500 nM, same 322 
concentration as Kaufman et al, 2016) via the patch pipette during whole-cell current-clamp 323 
recording from identified SNpc DNs. To ensure consistency, all molar concentrations were 324 
based on the molar mass of monomeric alpha-synuclein as the samples probably contain a  325 
range of aggregate sizes (see above).  Electrophysiological parameters were then measured 326 
from the voltage responses to step currents (standard IV, SIV) and naturalistic current 327 
injections (dynamic IV, DIV). The currents for SIV and DIV were injected at 8-minute 328 
intervals for the duration of recordings (32 minutes; Kaufmann et al, 2016). In control 329 
experiments, the same volume of vehicle (2 l PBS) was added to the intracellular solution. 330 
Recordings ( -syn aggregates, monomers or vehicle) were made from SNpc dopaminergic 331 
neurons in interleaved slices to minimise variation.  332 
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At time zero (a few minutes following whole-cell breakthrough) there was no significant 333 
difference in the measured parameters from SIVs (membrane potential P = 0.4657, 334 
resistance P = 0.2747 and firing rate P = 0.8511, Table 1) between neurons which had 335 
received either vehicle, -syn monomers or aggregates. Thus, the recording quality and 336 
neuronal properties were comparable between the experimental groups. However, as 337 
illustrated in the example in Fig 4A, there were marked changes in the SIV during recording 338 
from neurons in which -syn aggregates had been introduced.  The changes in SIV, 339 
reduction in voltage responses and decrease in firing rate at positive potentials, were 340 
indicative of a significant fall in neuronal resistance and the opening of a membrane channel. 341 
Such large changes in the SIV did not occur in the neurons that received either -syn 342 
monomers or vehicle (Fig 4B, C). For the neurons injected with -syn aggregates, after 32 343 
minutes of recording, the resistance was significantly (p = 0.0029, n = 11) reduced to 63 ± 344 
9.21 % of the resistance measured at 0 mins (Fig 4D). There was no significant changes in 345 
the resistance for neurons injected with either -syn monomers (P = 0.4688, n = 6) or 346 
vehicle (P = 0.0645, n = 10) over the duration of recordings (at 32 mins IR was 94 ± 5% of 347 
the resistance measured at time 0 mins for vehicle and 99 ± 9 % of resistance measured at 348 
time 0 mins for monomers, Fig 4D). At the 32-minute time point there was a significant (P = 349 
0.0007) difference in resistance between the neurons that received -syn monomers or 350 
vehicle to those where -syn aggregates were introduced. We investigated the time at which 351 
-syn aggregates began to affect neuronal resistance and found that the difference in 352 
resistance between control and aggregated and monomeric -syn neurons first became 353 
significant at the 16 minute time point (p = 0.0048; Figure 4D).  Thus, the resistance started 354 
to fall (presumably as membrane channels opened) between 8 to 16 minutes after -syn 355 
aggregate introduction into the neuron at whole-cell break through.  356 
The recorded neurons had a membrane potential of around -55 mV (see Table 1 357 
supplementary data) at the start of recordings. For all experimental conditions, the 358 
membrane potential slowly and weakly depolarised over the duration of the recordings (Fig 359 
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4E). For vehicle, the mean depolarisation (ΔVm) was 6.2 ± 1.82 mV after 32 minutes of 360 
recording (P = 0.0234, n = 10), for -syn monomers ΔVm was 3.8 ± 1.2 mV (P = 0.0938, n = 361 
6) and for -syn aggregates ΔVm was 6.8 ± 1.85 mV (P = 0.0107, n = 11). There was no 362 
statistically significant difference between the membrane potentials of the control (vehicle 363 
and monomers) vs -syn aggregates across the duration of the recordings (P = 0.3273). 364 
Thus although -syn aggregates markedly reduced neuronal resistance they did not produce 365 
a significant change in the membrane potential.  366 
For control neurons (vehicle), although the membrane potential was depolarised, the change 367 
in firing rate did not reach significance (P = 0.1895, measured from the naturalistic current 368 
injection, firing rate at 32 mins was 124.7 ± 1.3 % of the firing rate at time 0 mins, n = 10, Fig 369 
4F, G).  For neurons which received -syn monomers, although the membrane potential was 370 
depolarised there was also no significant (P > 0.9999) change in the firing rate (measured 371 
from the naturalistic current injection, firing rate at 32 mins was 120.4 ± 2.4 % of the firing 372 
rate at time 0 mins, n = 6, Fig 4F, G). For the neurons which had -syn aggregates 373 
introduced, there was a significant (P = 0.0020) reduction in the firing rate (at 32 mins the 374 
firing rate was 42.3 ± 9.3 % of the firing rate measured at 0 mins, n = 11, Fig 4F, G). When 375 
comparing control (vehicle and monomers) vs -syn aggregates there was a significant 376 
difference in the firing rate at 32 minutes (P = 0.0061). This fall in firing rate induced by -377 
syn aggregates is consistent with the marked fall in neuronal resistance.  378 
Alpha-synuclein aggregates decreased the occurrence of rebound firing following the 379 
termination of hyperpolarisation steps (73 % of neurons (8/11) showed rebound firing at 0 380 
mins, but only 18 %  (2/11) till showed it after 32 minutes of recording).  In contrast, all the 381 
control neurons that initially displayed rebound firing (60 %, (6/10)) still showed it after 32 382 
minutes of recording.  Aggregated -syn also reduced the occurrence of tonic firing (64 % of 383 
neurons (7/11) were initially spontaneously active but after 32 minutes only 27 % (3/11) of 384 
neurons were still active). For control neurons, 80 %  (8/10) initially displayed tonic firing, 385 
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with 60 %  (6/10) still active after 32 minutes of recording.  We examined at what time the 386 
neurons stopped spontaneously firing and found that on average control (vehicle) neurons 387 
that ceased firing stopped firing at 26 ± 3.7 minutes, which was similar to the time for 388 
neurons that received -syn monomers (28 ± 3.64 minutes). The neurons that received -389 
syn aggregates stopped firing significantly earlier (15.1 ± 2.33 minutes) than either control 390 
(vehicle) neurons (P = 0.0274) or neurons that received -syn monomers (P = 0.0392).  391 
 392 
 393 
Further analysis of the effects of -syn aggregates on dopaminergic neurons using 394 
the dynamic IV curve  395 
In control neurons (vehicle) the DIV curve did not markedly change throughout the duration 396 
of recordings (Fig 5A). In contrast -syn aggregates induced significant changes to the DIV, 397 
in particular increasing the slope (Fig 5B). These effects were not observed with -syn 398 
monomers (Fig 5C). For all experimental conditions, there were no significant changes in the 399 
cellular capacitance (P = 0.18, Fig 5E). Thus, the introduction of -syn aggregates had no 400 
effect on the electrotonic properties of the neurons, by for example electrically isolating 401 
compartments. Aggregated -syn markedly increased the membrane conductance (272 % 402 
of the conductance at 0 mins by 32 minutes, P = 0.001, Fig 5D). In control neurons (vehicle 403 
or -syn monomers) there was a small increase in conductance (vehicle conductance was 404 
135 % of the conductance at 0 mins by 32 minutes P = 0.009; -syn  monomer conductance 405 
was 141.2 % of the conductance at 0 mins by 32 minutes, ns) over the duration of 406 
recordings. At 32 minutes there was no significant (P > 0.9999) difference between the 407 
conductance of vehicle and -syn monomer treated neurons. In contrast, the conductance of 408 
-syn aggregate treated neurons was significantly (P = 0.0003) larger than vehicle treated 409 
neurons. There was no significant differences in the other extracted parameters: resting 410 
membrane potential, spike potential or spike-resting potential between the 3 experimental 411 
 
 17 
conditions (Fig 5F-H). Thus the reduction in excitability induced by -syn aggregates is only 412 
due to a change in conductance rather than changes in for example the potential difference 413 
between rest and threshold.  414 
The decrease in conductance and firing rate caused by alpha synuclein is in part due 415 
to the opening of KATP channels 416 
Previous studies have shown that either blocking ATP-sensitive K channels (KATP) or 417 
genetically deleting them it has protective effects on dopaminergic neurons in PD rodent 418 
models (Liss et al 2005; Zhang et al 2012). There has also been a recent preprint that shows 419 
that the effects of -syn aggregates on spontaneous firing can be prevented by blocking 420 
KATP channels (Thakur et al, 2019).  To investigate whether the increase in membrane 421 
conductance that we have observed could be prevented by inhibiting KATP channel 422 
opening, we used the classic KATP blocker glibenclamide (Light and French 1994; Jiang 423 
and Haddad 1997). We first investigated whether the presence of glibenclamide throughout 424 
recordings had any effect on the electrophysiological properties of SNpc dopaminergic 425 
neurons (Fig 6A). There was no significant difference in any of the measured parameters 426 
(from SIVs, membrane potential P = 0.3791, resistance P = 0.2294, firing rate P = 0.6548) at 427 
0 mins between neurons from slices which had been pre-incubated with glibenclamide (1 428 
M, n = 6) compared to neurons in control slices (both with vehicle in the patch pipette). 429 
These neuronal parameters did not significantly change over the duration of the recordings 430 
with glibenclamide present: resistance (after 32 mins 99 ± 7.5 % of the resistance at time 0 431 
mins, P = 0.08438, n = 6) or firing rate (after 32 mins 112.1 ± 26.6 % of the firing rate at time 432 
0 mins, P = 0.5625, Fig 6A). Thus, glibenclamide had no significant effect on neuronal 433 
properties measured from SIVs that could occlude the actions of -syn aggregates.  434 
We then made whole-cell recordings with -syn aggregates in the patch pipette in slices pre-435 
incubated in glibenclamide (1 M, Fig 6B). The fall in resistance and firing rate that was 436 
observed in the presence of -syn aggregates did not occur when the slices were incubated 437 
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with glibenclamide. There was no significant reduction in resistance or firing rate over the 438 
duration of recording when slices were incubated with glibenclamide suggesting that the 439 
action of -syn aggregates could least in part be mediated by KATP channels. The 440 
resistance at 32 mins was 90 ± 8.62 % of the resistance at time 0 mins (cf 63 % without 441 
glibenclamide) which was not statistically significant (P = 0.25, n = 6) from the resistance at 442 
time zero. The firing rate was 80.14 ± 12.89 % of the rate at time 0 mins (vs 42 % without 443 
glibenclamide) which was not statistically significant from the firing rate at time 0 mins (P = 444 
0.353, n = 6). Both sets of recorded neurons (vehicle and -syn aggregates) weakly 445 
depolarised over the 32 minutes of recording to a similar degree to that of non-glibenclamide 446 
treated slices (vehicle, ΔVm 4.66 ± 2.6 mV and -syn aggregates, ΔVm 5.5 ± 2.05 mV, Fig 447 
6E). 448 
We further investigated the effects of the glibenclamide on the effects of -syn aggregates - 449 
using the dynamic IV (DIV). The DIV curves in glibenclamide (vehicle) and in glibenclamide 450 
( -syn aggregates) did not markedly change throughout the duration of the recordings (Fig 451 
7A, B). As observed previously (without glibenclamide) there was also no change in 452 
capacitance over the duration of the recordings ((vehicle P = 0.0625, -syn aggregates P = 453 
0.0625, Fig 7C).  In the presence of glibenclamide, there was no significant increase (P = 454 
0.0625) in whole cell conductance for vehicle receiving neurons over the duration of the 455 
recordings or only a small increase for -syn aggregate receiving neurons (P = 0.0313). 456 
After 32 minutes, there was no significant (P = 0.3095) difference between the whole cell 457 
conductance of neurons receiving vehicle and those receiving -syn aggregates (Fig 7D, H).  458 
For all the other extracted parameters there was no difference between vehicle and -syn 459 
aggregate receiving neurons for the duration of recordings (Fig 7E-G).  Thus, as observed 460 
with SIV anlysis, the KATP inhibitor glibenclamide significantly reduced the effects of -syn 461 
aggregates. 462 
  463 
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 464 
Discussion 465 
In this study we have used whole-cell patch-clamp recording to introduce a known 466 
concentration and form of aggregated alpha synuclein ( -syn) into single substantia nigra 467 
pars compacta (SNpc) dopaminergic neurons in acutely isolated mouse slices. Although it is 468 
possible, using emerging technologies, to isolate only the oligomeric fractions (Kumar et al, 469 
2020) we have not utilised such methods. Thus we cannot exclude the possibility that some 470 
small fibrils are present in our -syn oligomer samples. While the majority of the species in 471 
our -syn samples appeared to have an oligomeric structure (Fig 3) other forms of small 472 
aggregates maybe present (for example small ~50 nm fibrils; Polinski et al, 2018). We have 473 
therefore used the term -syn aggregates rather than -syn oligomers. As outlined in 474 
previous studies (Kaufmann et al 2016; Hill et al 2019) delivery of species via the patch 475 
pipette has a number of advantages, the main one being that it is possible to measure early 476 
changes in the properties of a single neuron in a network that is free from pathology. This 477 
method also bypasses any slow uptake steps and each neuron acts as its own control, as at 478 
early time points only low concentrations of the species will have diffused into the neuron. 479 
Here we have introduced 500 nM of -syn aggregates, which is a concentration in line with 480 
previous studies (see Kaufmann et al, 2016). However, as noted in the methods, the actual 481 
concentration of aggregates will be considerably lower. It would be interesting in future 482 
experiments to investigate whether there is a concentration dependant effect of -syn 483 
aggregates, with for example lower concentrations having a slower onset (see Hill et al 484 
2019).   485 
We used both standard current-voltage relationships (SIV, with step current injections) and 486 
the dynamic current-voltage relationships (DIV, with naturalistic current injection) to extract 487 
neuronal parameters.  Both approaches measured a marked increase in whole-cell 488 
conductance (fall in neuronal resistance), which occurred between 8-16 minutes after whole-489 
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cell break through. There were no significant changes in membrane potential, cell 490 
capacitance or spike threshold between neurons receiving -syn aggregates, -syn 491 
monomers or vehicle. The increase in conductance significantly reduced the firing rate, both 492 
induced (by current injection) and spontaneous, and abolished rebound firing following 493 
hyperpolarising current steps. The increase in conductance increased the linearity of the DIV 494 
curve effectively shunting the depolarisation-activated conductance increase just below 495 
threshold that was present in some neurons at 0 minutes (whole-cell breakthrough).  496 
Obtaining similar results using two independent methods for the extraction of neuronal 497 
parameters strengthens the robustness of the observation that -syn aggregates increase 498 
whole-cell conductance.  There were minor differences in the precise values of the neuronal 499 
parameters extracted using DIV compared to those extracted with SIV, which is to be 500 
expected given the different conductance states of the cell in the two protocols.  For the DIV, 501 
the voltage varies across a wide range during naturalistic stimulation (mimicking in vivo 502 
synaptic activity) activating and inactivating a variety of conductances. In contrast the SIV 503 
extracts parameters over a much smaller range of voltages from essentially quiescent cells. 504 
For example, if the DIV and SIV curves are compared, the DIV conductances are initially 505 
lower (at 0 minutes) for all of the experimental conditions (vehicle, aggregates and 506 
monomers) and then increase. This could be interpreted as one or more of the 507 
conductances being slightly more inactivated during the DIV protocol. It could then be that 508 
this inactivation is relieved as the neuronal resting potential slowly depolarises during the 509 
recording. Alternatively, it could be that another conductance activates as the neuron 510 
depolarises, but in a range that is not accessed by the hyperpolarising SIV current steps. In 511 
either case, a different range of voltages is probed between DIV and SIV and so differences 512 
in the extracted parameters will occur. The fact that the same significant conductance 513 
increase (resistance decrease) is clearly seen in these two very different protocols attests to 514 
the robustness of the effect of alpha-synuclein on these neurons. 515 
 516 
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 517 
The increase in whole-cell conductance is reduced by the KATP channel blocker 518 
glibenclamide  519 
The effects of the ATP-sensitive K+ channel (KATP) inhibitor glibenclamide (Light and 520 
French 1994) suggests the involvement of KATP channels (but see caveats below).  KATP 521 
channels are inwardly rectifying K+-selective ion channels that are inhibited by intracellular 522 
ATP. KATP channels provide a link between the energy state of cells and their electrical 523 
activity acting as a metabolically controlled “brake on excitation”. A decrease in sub-524 
membrane ATP levels and an accompanying rise in ADP concentration (during activity) 525 
triggers KATP channel opening dropping neuronal resistance and hyperpolarising the 526 
membrane potential (Stanford and Lacey 1995; Seino, 1999; Haller et al., 2001). It is well 527 
established that SNpc dopaminergic neurons express KATP channels (Schiemann et al 528 
2012; Liss et al 2005). The lack of effect of the KATP inhibitor glibenclamide under control 529 
conditions suggests that few KATP channels are open at rest. This is perhaps not surprising 530 
as there was 2 mM ATP in the intracellular patch solution, although some KATP channels 531 
have a low affinity for ATP and would still be open with this level of ATP (for example see 532 
Allen and Brown 2004).  The effects of -syn aggregates on conductance and its inhibition 533 
by glibenclamide are consistent with the opening of KATP channels (but see below).  These 534 
effects occurred in the presence of 2 mM intracellular ATP suggesting a direct effect of -535 
syn aggregates on the KATP channel, rather than via a reduction in intracellular ATP 536 
concentration (by for example mitochondrial dysfunction). KATP channel openers like 537 
diazoxide have previously been shown to act by open KATP channels in the presence of 538 
ATP (Schwanstecher et al 1998) so it is possible that -syn aggregates could have a similar 539 
action. 540 
The effects on cell conductance and its prevention with glibenclamide are consistent with the 541 
-syn aggregates increasing KATP channel open probability. However, there was little or no 542 
 
 22 
associated membrane potential hyperpolarisation (measured with SIV and with DIV), which 543 
has been observed in most reports of KATP channel activation (for example see Stanford 544 
and Lacey, 1995; Allen and Brown 2004). The equilibrium potential for K+ is ~ -95 mV, so 545 
opening of KATP channels would be expected to produce a large hyperpolarisation of the 546 
membrane potential (as the resting potential at time zero was ~-55 mV). However, the 547 
membrane potential hyperpolarisation could possibly be counteracted by the opposing 548 
activation of hyperpolarization-activated, cyclic nucleotide-gated HCN channels I(h) which 549 
have a reversal potential between -40 to -30 mV (Mayer and Westbrook 1983). It may be 550 
that the opening of a relatively small number of KATP channels changes the input 551 
resistance/conductance of neurons but is insufficient to change the membrane potential 552 
against the responsive reaction of I(h).  In contrast opening of many KATP channels will 553 
overcome the effects of I(h) leading to robust membrane hyperpolarisation, which as 554 
reported for SNpc dopaminergic neurons by lowering intracellular ATP concentration or 555 
using KATP channel opening drugs (Stanford and Lacey 1995).   556 
The inhibitory effects of glibenclamide on -syn responses are consistent with the opening of 557 
KATP channels but additional evidence is required to provide definitive evidence for a role 558 
for KATP channels in the effects of -syn aggregates. One possible approach is to occlude 559 
the effects of -syn aggregates using a pharmacological opener of KATP channels (such as 560 
diazoxide). However these experiments maybe be difficult to interpret. The KATP channel 561 
opener will markedly reduce resistance and hyperpolarise the recorded neuron. This may 562 
occlude the effects of -syn aggregates simply by shunting the neuron and moving it closer 563 
to EK rather than acting through the same channel. Other possible approaches include the 564 
use of transgenic animals, where the KATP gene has been deleted, or using cell lines 565 
expressing specific KATP channels.  Alternate possibilities for the lack of membrane 566 
hyperpolarisation include the opening of other channels that depolarise the neuron.  For 567 
example, it has been reported that -synuclein itself can form non-selective cation channels 568 
(Mironov et al, 2015). 569 
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It took on average between 8-16 minutes of dialysis for the effects of –syn aggregates on 570 
whole cell conductance to become significant. It may be that the concentration within the 571 
neuron has to reach a sufficient level to open membrane channels. For comparison 572 
introduction of aggregated tau (444 nM) into pyramidal neurons started to have effects on 573 
the action potential within the first 10 minutes (Hill et al, 2019). In this study we chose to 574 
focus on the effects of introducing -syn aggregates into substantia nigra dopaminergic 575 
neurons. Given that the neighbouring population of VTA dopaminergic neurons have 576 
differences in their KATP channel expression (Liss et al, 2005), it might be expected that -577 
syn aggregates may have a different effect in these cells (which would additional evidence 578 
for a role of KATP channels). This may contribute to the varying vulnerability of these two 579 
dopaminergic nuclei in diseases like Parkinson’s disease. 580 
The accumulation of -syn aggregates in SN dopaminergic neurons during Parkinson’s 581 
disease progression could potentially result in the prolonged activation of membrane 582 
channels (such as KATP) which will chronically reduce electrical activity, the amount of 583 
dopamine released (Patel et al, 2011) and will be detrimental to neuron function.  If KATP 584 
channels are involved then there will be a loss of the metabolic feedback mechanism. 585 
Consistent with this KATP involvement, there is retrospective epidemiological evidence of a 586 
reduced risk for Parkinson’s disease in type 2 diabetic patients that were treated with KATP 587 
inhibitors (Schernhammer et al, 2011; Wahlqvist et al, 2012; Cereda et al, 2013; Lu et al, 588 
2014; Brauer et al, 2015).  589 
Conclusion 590 
In this study we have combined electrophysiological recording with detailed and thorough 591 
analysis to characterize the effects of introducing aggregated -Syn directly into single 592 
mouse dopaminergic neurons in the substantia nigra. Aggregated -Syn caused a significant 593 
increase in conductance and decrease in firing rate without altering the resting membrane 594 
potential, capacitance or spike threshold. Changes to conductance and firing rate occurred 595 
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8-16 minutes after whole-cell breakthrough and were specific to aggregates (they were not 596 
observed when monomeric alpha synuclein was introduced). The effects could be prevented 597 
by pre-incubating the slices in ATP-sensitive potassium channel (KATP) inhibitor 598 
glibenclamide, despite the high concentration of ATP present in the patch electrode. This 599 
suggests that aggregated -Syn may increasing the opening probability of KATP channels, 600 
resulting in an increase in conductance, a reduction in neuronal excitability and likely also a 601 
decrease in dopamine release and overall cell function.  602 
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Legends  732 
Figure 1: Whole-cell patch-clamp recording from dopaminergic neurons in the SNpc  733 
(A) Example membrane potential trace recorded from a putative dopaminergic neuron (DN) 734 
in the substantia nigra which showed characteristic spontaneous action potential firing. 735 
Dopamine (30 μM) hyperpolarised the neuron from -62 mV to -70 mV and stopped the action 736 
potential firing. (B) The different input currents delivered to putative DNs. SIV is the standard 737 
step current protocol, 3 s duration steps starting at -200 pA and increasing by 50 pA until the 738 
neuron exhibits a regular firing pattern. DIV uses a fluctuating naturalistic noisy current trace 739 
(see methods for details) which is also used to determine action potential firing rate. (C) 740 
(Top) Membrane potential traces in response to current steps. The recorded neuron displays 741 
characteristic features of DNs: a large sag in response to hyperpolarising steps (arrow) and 742 
rebound firing (*). (Bottom) Membrane potential trace from the same cell in response to 743 
naturalistic current injection. The neuron can be seen to be firing at rest (*) which is a 744 
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characteristic feature of these neurons.  (D) (Top) Membrane potential traces in response to 745 
current steps following application of dopamine (30 M). The sag is reduced, the membrane 746 
potential hyperpolarised, the firing reduced, and the rebound firing is absent. (Bottom) 747 
Membrane potential trace from the same cell in response to naturalistic current injection in 748 
dopamine (30 M). The neuron has stopped firing at rest, fires less frequently during current 749 
application and is hyperpolarised. (E) (Top) Membrane potential traces in response to 750 
current steps in the presence of the I(h) blocker ZD7288 (100 M) are similar to that 751 
previously reported for DN (Harris and Constanti, 1995). The sag response to 752 
hyperpolarising current steps is markedly reduced, the resting membrane potential is 753 
hyperpolarised, the firing rate reduced and the voltage response following the spike is 754 
altered. (Bottom) Membrane potential response of the same neuron to the naturalistic 755 
injected current in ZD7288 (100 M). (F) Tyrosine hydroxylase (TH) immunohistochemistry 756 
confirms that the recorded neurons were DNs. Neurons were filled with AF594 dye (red) via 757 
the patch pipette and then slices were stained for TH (green). The merged image shows that 758 
the recorded neurons express tyrosine hydroxylase and are therefore dopaminergic. The 759 
scale bar is 50 m.  760 
 761 
Figure 2: Extracting neuronal parameters using standard-IV (SIV, panel A) and 762 
dynamic-IV (DIV, panels B-D) methodologies. For the SIV measurements: (A) Applied 763 
current and voltage response. Arrow shows location of voltage measurement for the 764 
calculation of neuronal resistance (peak voltage deflection). For the dynamic IV 765 
measurements: (B) Naturalistic stimulation current and voltage response. (C) The estimated 766 
ionic current as a scatter plot against voltage (points). The dynamic-IV curve (black) is the 767 
typical ionic current at a particular voltage where data within 200 ms post-spike was not 768 
included to avoid the effects of transitory spike-generated currents. (D) The dynamic IV 769 
curve (black) and its linear fit to the ohmic component (green, from hyperpolarised voltages 770 
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to the resting voltage). Inset, illustrates the isolated outward current. See Methods for further 771 
details of the SIV and DIV fitting procedures. 772 
Figure 3: Structural analysis of alpha synuclein samples.  773 
Electron micrographs of negative-stain-TEM analysed protein samples. The sample (5 l) 774 
was applied onto a copper grid and fixed with uranyl acetate. Magnification is 60,000x. (A) 775 
Tau aggregates (for reference) showing aggregated form. Inset, higher magnification 776 
showing annular form of aggregates (B) Alpha synuclein monomers show no aggregation. 777 
Inset, higher magnification showing no structural form (C) Alpha synuclein aggregates 778 
display many large fibrils (preformed fibrils PFF). Inset, example of fibrils at higher 779 
magnification (D) Alpha synuclein fibrils were added to intracellular patch solution and then 780 
sonicated for 15 minutes to form small aggregates. Inset, illustrates the annular form of 781 
aggregates. Scale bar = 200 nm.   782 
 783 
Figure 4. Alpha-synuclein aggregates induce a time-dependent decline in firing rate 784 
and significant fall in neuronal resistance.  785 
Example current-voltage relationships (SIV) for dopaminergic neurons injected with -syn 786 
aggregates (A), vehicle (B) and -syn monomers (C). Current steps (starting at -200pA and 787 
increasing by 50 pA until a regular firing pattern was induced) were used to construct SIVs. 788 
Recordings display SIVs at time points between whole cell breakthrough (0 mins) and up to 789 
32 mins.  The neuron which had the -syn aggregates introduced (A) shows a clear 790 
reduction in the voltage responses and a fall in the firing rate at positive potentials, whereas 791 
the neurons that received either vehicle or -syn monomers show no significant changes (B, 792 
C).  (D) Mean neuronal resistance plotted against time for control (vehicle) neurons and 793 
neurons that had either -syn aggregates or monomers introduced. For the neurons injected 794 
with α-syn aggregates, after 32 minutes of recording, the resistance was significantly (p = 795 
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0.0029) reduced to 63 ± 9.21 % of the resistance measured at 0 mins. At the 32-minute time 796 
point there was a significant (P = 0.0002) difference in resistance between the neurons that 797 
received α-syn monomers or vehicle to those where α-syn aggregates were introduced. (E) 798 
Mean resting membrane potential plotted against time for control (vehicle) neurons and 799 
neurons that had either -syn aggregates or monomers introduced. Under all experimental 800 
conditions, the neurons slowly depolarised over the time course of the recording. For 801 
vehicle, the mean depolarisation (ΔVm) was 6.2 ± 1.82 mV after 32 minutes of recording (P 802 
= 0.0234), for α-syn monomers ΔVm was 3.8 ± 1.2 mV (P = 0.0938) and for α-syn 803 
aggregates ΔVm was 6.8 ± 1.85 mV (P = 0.0107). (F) Normalised firing rate plotted against 804 
time for control (vehicle) neurons and neurons that had either -syn aggregates or 805 
monomers introduced (firing rate was measured from naturalistic current injection). Data is 806 
normalised to the firing rate at time 0 (whole cell break through). Despite depolarising by a 807 
comparable amount to the control (vehicle) and monomer introduced neurons, -syn 808 
aggregates induced a significant reduction in the firing rate over time (P=0.0020) consistent 809 
with the fall in input resistance. When comparing control (vehicle and α-syn monomers) and 810 
α-syn aggregates there was a significant difference in the firing rate at 32 minutes (P = 811 
0.0061). (G) The same section of voltage trace taken during the injection of naturalistic 812 
current in example neurons injected with vehicle, -syn monomers and -syn aggregates to 813 
illustrate the changes in firing pattern over the duration of recordings.  814 
 815 
Figure 5. Intracellular diffusion of alpha-synuclein aggregates results in a progressive 816 
conductance increase in the dynamic I-V curve.  817 
Example dynamic IV curves (DIV) from neurons that had control (vehicle, A), alpha-818 
synuclein ( -syn) aggregates (B) or monomeric -syn (C) introduced. Each graph shows the 819 
DIV curve at 8 minute time points throughout recordings (32 minutes). There is a marked 820 
increase in the gradient of the DIV (conductance) when oligomeric -syn was introduced. (D-821 
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H) Extracted neuronal parameters averaged across recordings for the time periods during 822 
recordings (n =1 0 for control, n = 11 -syn aggregates and n = 6 -syn, monomers). 823 
Capacitance (D) showed no significant change over time for all the experimental conditions. 824 
Though both control (vehicle) and monomeric -syn neurons showed a small increase in 825 
conductance (E) over time (~35% and ~40% after 32 minutes, respectively), the average 826 
conductance for the cells receiving -syn aggregates was almost threefold its initial value by 827 
32 mins (~170 % increase; P=0.009). At 32 minutes there was no significant (P > 0.9999) 828 
difference between the conductance of vehicle and α-syn monomer treated neurons. In 829 
contrast, the conductance of α-syn aggregate treated neurons was significantly (P = 0.0003) 830 
larger than vehicle treated neurons. Though both the resting potential (F) and spike 831 
threshold (G) slightly increased with time, the potential difference from resting potential to 832 
spike threshold remained constant with time. The decrease in excitability of the cells 833 
receiving -syn aggregates was therefore mediated by a conductance shunt rather than an 834 
increase in the relative threshold for spike initiation. 835 
Figure 6. The effects of alpha-synuclein aggregates on electrophysiological properties 836 
are reversed by glibenclamide  837 
(A) Standard current-voltage relationship (SIV) for an example control neuron (injected with 838 
vehicle) in the presence of the KATP channel inhibitor glibenclamide (1 M). Current steps 839 
(starting at -200pA and rising by 50 pA) were injected until a regular firing pattern was 840 
induced. SIV traces are displayed at time points between whole cell breakthrough (0 mins) 841 
and the end of recording (32 mins). The neuron remained stable for the duration of the 842 
recording with little change in the SIV. (B) As in (A), but with -syn aggregates (500 nM, final 843 
concentration) added to the internal recording solution. The decrease in input resistance and 844 
firing rate that was observed with -syn aggregates in control conditions was markedly 845 
reduced by the presence of glibenclamide.  (C) Mean resistance measurements over time 846 
for control (vehicle) vs -syn aggregates in the presence of glibenclamide. The fall in 847 
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resistance was reduced compared to that for -syn aggregate-injected neurons recorded in 848 
normal aCSF. (D) Mean resting membrane potential measurements plotted against time for 849 
vehicle vs -syn aggregates in the presence of glibenclamide. (E) Mean firing rate 850 
(measured from naturalistic current injection) plotted against time for vehicle vs -syn 851 
aggregates in the presence of glibenclamide. The fall in firing rate was reduced compared to 852 
that for -syn aggregate-injected neurons in normal aCSF. The red dotted line represents 853 
the effects observed with the introduction of -syn aggregates in the absence of 854 
glibenclamide, this data is repeated from Figure 4 and is intended to provide a visual 855 
reference to demonstrate the partial recovery.  856 
Figure 7.  The KATP channel inhibitor glibenclamide blunts the effects of -syn 857 
aggregates on the DIV.   858 
Slices were incubated in glibenclamide (1 M) to block KATP channels. (A) Example 859 
dynamic IV curves for a neuron that had vehicle introduced. (B)  Example dynamic IV curves 860 
for a neuron that had -syn aggregates introduced. For (A and B) each graph shows the DIV 861 
curves at 8 minute time points throughout recordings (32 minutes). There are no marked 862 
changes in the DIV across time for the two experimental conditions. (C-H) Extracted 863 
neuronal parameters averaged across recordings for the time periods during recordings (n = 864 
6 for vehicle, n = 6 -syn aggregates). Capacitance (C) showed no significant change over 865 
time for all the experimental conditions. (D) There was a small increase in whole-cell 866 
conductance for neurons with -syn aggregates, but the percentage change was closer to 867 
vehicle than to -syn aggregates without glibenclamide. Resting potential (F) and spike 868 
threshold (G) also slightly increased with time, the potential difference from rest potential to 869 
spike threshold remained constant with time. (H) Graph plotting the normalised conductance 870 
(normalised to the conductance at time 0 mins) for all experimental conditions. Using a 871 
Kruskal Wallis ANOVA, we confirmed that both time and experimental condition had a 872 
significant effect on conductance (P < 0.0001 and P < 0.0001 respectively). At 32 mins, the 873 
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neurons with -syn aggregates injected have a significantly greater conductance than any of 874 
the other experimental conditions (vs control P < 0.0001, vs monomer P = 0.0003, vs Glib + 875 
control P < 0.0001, vs Glib + aSyn P = 0.0045; Dunn’s post hoc analysis). No other 876 
experimental conditions were significantly different from each other. 877 
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Table 1: Electrophysiological parameters measured for dopaminergic neurons at time zero for all experimental treatments888 
 
Vehicle/ control aSyn  aggregates aSyn monomers Glib + vehicle Glib + aSyn  aggregates 
Parameter Mean SEM SD Mean SEM SD Mean SEM SD Mean SEM SD Mean SEM SD 
RMP (mV) -55.8 ± 1.2 ± 3.79 -55.4 ± 1.23 ± 4.10 -56.8 ± 1.30 ± 3.18 -53.2 ± 2.14 ± 5.24 -60.4 ± 1.82 ± 4.08 
R in (MΩ) 338 ± 17.6 ± 55.8 312 ± 17.1 ± 56.8 359 ± 42.2 ± 103.3 386 ± 25.2 ± 61.7 294 ± 41.9 ± 93.6 
Firing Rate (Hz) 1.63 ± 0.39 ± 0.12 2.51 ± 1.57 ± 0.47 2.38 ± 1.14 ± 0.46 2.27 ± 1.15 ± 0.47 2.04 ± 1.29 ± 0.52 
C (pF) 88.8 ± 5.74 ± 14.1 107.8 ± 5.84 ± 14.3 80.73 ± 15.1 ± 37.0 81.16 ± 8.54 ± 20.9 117 ± 22.3 ± 54.7 
g (nS) 2.29 ± 0.2 ± 0.49 2.78 ± 0.2 ± 0.49 1.99 ± 0.3 ± 0.73  2.39 ± 0.29 ± 0.71 3.67 ± 0.55 ± 1.35  
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Data Figure Statistical Test Test values P value 
0 mins, all conditions, RMP Figure 4 Kruskal-Wallis ANOVA H (4) = 0.5385 P = 0.4657 
0 mins,   all conditions , IR Figure 4 Kruskal-Wallis ANOVA H (4) = 2.109 P = 0.2727 
0 mins all conditions , FR Figure 4 Kruskal-Wallis ANOVA H (4) = 1.395 P = 0.8511 
0 mins vs 32 mins, aSyn aggregates, IR Figure 4 Wilcoxon signed-rank test W(+) = 2.0, W(-) = 64.0, 
Z = 2.7 
P = 0.0029 
0 mins vs 32 mins, aSyn monomers, IR Figure 4 Wilcoxon signed-rank test W(+) = 6.5, W(-) = 14.5, 
Z = 0.73 
P = 0.4688 
0 mins vs 32 mins, vehicle, IR Figure 4 Wilcoxon signed-rank test W(+) = 46.0, W(-) = 9.0, 
Z = -1.83 
P = 0.0645 
32 mins,  aSyn aggregates,  aSyn 
monomers and vehicle, IR 
Figure 4 Kruskal-Wallis ANOVA H (2) = 14.53 P = 0.0007 
16 mins,  aSyn aggregates,  aSyn 
monomers and vehicle, IR 
Figure 4 Kruskal-Wallis ANOVA H (2) = 10.67 P = 0.0048 
0 mins vs 32 mins, vehicle, RMP Figure 4 Wilcoxon signed-rank test W(+) = 41.5, W(-) = 3.5, 
Z = -2.19 
P = 0.0234 
0 mins vs 32 mins, aSyn aggregates, 
RMP 
Figure 4 Wilcoxon signed-rank test W(+) = 61.0, W(-) = 5.0, 
Z = -2.44 
P = 0.0107 
0 mins vs 32 mins, aSyn monomers, 
RMP 
Figure 4 Wilcoxon signed-rank test W(+) = 19.5, W(-) = 1.5 
Z = -1.79 
P = 0.0938 
32 mins,  aSyn aggregates,  aSyn 
monomers and vehicle, RMP 
Figure 4 Kruskal-Wallis ANOVA H (2) = 2.234 P = 0.3273 
0 mins vs 32 mins, vehicle, FR Figure 4 Wilcoxon signed-rank test W(+) = 14, W(-) = 41.0 
Z = -1.32 
P = 0.1895 
0 mins vs 32 mins, aSyn aggregates, FR Figure 4 Wilcoxon signed-rank test W(+) = 1.0, W(-) = 65.0 
Z = 2.8 
P = 0.0020 
0 mins vs 32 mins, aSyn monomers, FR Figure 4 Wilcoxon signed-rank test W(+) = 11, W(-) = 10.0 
Z = 0 
P > 0.9999 
32 mins,  aSyn aggregates,  aSyn 
monomers and vehicle, FR 
Figure 4 Kruskal-Wallis ANOVA H (2) = 10.21 P = 0.0061 
0 mins, all conditions, capacitance Figure 5 Kruskal-Wallis ANOVA H (4) = 6.269 P = 0.18 
0 mins vs 32 mins, aSyn aggregates, 
membrane conductance 
Figure 5 Wilcoxon signed-rank test W(+) = 66.0 , W(-) = 0  
Z = -2.89 
P = 0.001 
0 mins vs 32 mins, vehicle, membrane 
conductance 
Figure 5 Wilcoxon signed-rank test W(+) = 71.0 , W(-) = 7  
Z = -2.47 
P = 0.009 
32 mins,  aSyn monomers and vehicle, 
membrane conductance 
Figure 5 Mann-Whitney test Vehicle median = 
2.820, n=12, aSyn 
monomers = 2.820, 
n=6, U = 36 
P > 0.9999 
32 mins,  aSyn aggregates and vehicle, 
membrane conductance 
Figure 5 Mann-Whitney test aSyn aggregates 
median = 6.450, n = 11, 
P  = 0.0003 
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 889 
Table 2: A table of all of the statistical tests and associated results. 890 
vehicle median = 
2.820, n = 12, U = 11 
0 mins, vehicle and vehicle + glib, RMP Figure 6 Mann-Whitney test Vehicle median = -56, n 
= 10, Vehicle + Glib 
median = -54, n = 6, U 
= 21.50 
P = 0.3791 
0 mins, vehicle and vehicle + glib, IR Figure 6 Mann-Whitney test Vehicle median = 
338.3, n = 10, Vehicle + 
Glib median = 393, n = 
6, U = 18.50 
P = 0.2294 
0 mins, vehicle and vehicle + glib, FR Figure 6 Mann-Whitney test Vehicle median = 69.5, 
n = 10, Vehicle + Glib 
median = 86.5, n = 6, U 
= 25.50 
P = 0.6548 
0 mins vs 32 mins, vehicle + glib, IR Figure 6 Wilcoxon signed-rank test W(+) = 9.0, W(-) = 12.0 
Z = 0.21 
P  = 0.8438 
0 mins vs 32 mins, vehicle + glib, FR Figure 6 Wilcoxon signed-rank test W(+) = 7.0, W(-) = 14.0 
Z = 0.63 
P  = 0.5625 
0 mins vs 32 mins, aSyn + glib, IR Figure 6 Wilcoxon signed-rank test W(+) = 5.0, W(-) = 16.0 
Z = 1.04 
P = 0.25 
0 mins vs 32 mins, aSyn + glib, FR Figure 6 Wilcoxon signed-rank test W(+) = 7.0, W(-) = 14.0 
Z = 0.63 
P = 0.353 
0 mins vs 32 mins, aSyn + glib, 
membrane conductance 
Figure 7 Wilcoxon signed-rank test W(+) = 21.0, W(-) = 0   
Z = 0.63 
P = 0.0313 
32 mins, vehicle + glib and aSyn + glib, 
membrane conductance 
Figure 7 Mann-Whitney test Vehicle + glib median = 
4.675, n = 6, aSyn + glib 
median = 3.33, n = 6, U 
= 11 
P = 0.3095 
Normalised conductance over time, all 
conditions 
Conductance effect 
Time effect 
 
aSyn aggregates vs control 
aSyn aggregates vs monomers 
aSyn aggregates vs vehicle + glib 
aSyn aggregates vs aSyn + Glib 
 
Figure 7 Kruskal-Wallis ANOVA 
 
Dunn’s Posthoc analysis 
 
 
 
 
F (4, 180) = 6.806 
F (4, 180) = 11.01 
 
 
P < 0.0001 
P < 0.0001 
 
P < 0.0001 
P = 0.0003 
P < 0.0001 
P = 0.0045 
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Table 1: Electrophysiological parameters measured for dopaminergic neurons at time zero for all experimental treatments 
 
 
 
 
Vehicle/ control aSyn  aggregates aSyn monomers Glib + vehicle Glib + aSyn  aggregates 
Parameter Mean SEM SD Mean SEM SD Mean SEM SD Mean SEM SD Mean SEM SD 
RMP (mV) -55.8 ± 1.2 ± 3.79 -55.4 ± 1.23 ± 4.10 -56.8 ± 1.30 ± 3.18 -53.2 ± 2.14 ± 5.24 -60.4 ± 1.82 ± 4.08 
R in (MΩ) 338 ± 17.6 ± 55.8 312 ± 17.1 ± 56.8 359 ± 42.2 ± 103.3 386 ± 25.2 ± 61.7 294 ± 41.9 ± 93.6 
Firing Rate (Hz) 1.63 ± 0.39 ± 0.12 2.51 ± 1.57 ± 0.47 2.38 ± 1.14 ± 0.46 2.27 ± 1.15 ± 0.47 2.04 ± 1.29 ± 0.52 
C (pF) 88.8 ± 5.74 ± 14.1 107.8 ± 5.84 ± 14.3 80.73 ± 15.1 ± 37.0 81.16 ± 8.54 ± 20.9 117 ± 22.3 ± 54.7 
g (nS) 2.29 ± 0.2 ± 0.49 2.78 ± 0.2 ± 0.49 1.99 ± 0.3 ± 0.73  2.39 ± 0.29 ± 0.71 3.67 ± 0.55 ± 1.35  
